Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives. - Wikidata - wikimedia - TriplyDB

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

http://www.wikidata.org/entity/Q34157584

about

Graphene as cancer theranostic tool: progress and future challenges Graphene-Iodine Nanocomposites: Highly Potent Bacterial Inhibitors that are Bio-compatible with Human Cells.Continuous release of bone morphogenetic protein-2 through nano-graphene oxide-based delivery influences the activation of the NF-κB signal transduction pathway.Graphene-based nanomaterials as molecular imaging agents.Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment Curcumin-loaded graphene oxide flakes as an effective antibacterial system against methicillin-resistant Staphylococcus aureus.Graphene and graphene-based nanocomposites: biomedical applications and biosafety

P2860

Q26860274-7074E51E-7751-4887-9BFD-E388E598627F Q30391474-B1E8BAA6-E4AD-418A-A612-CAB422E8D9D6 Q37649880-1BAA6841-95FC-4371-8E8C-1C3E4590CBF6 Q38413308-790930D9-DA48-40B9-9536-CA64F1DC3C6C Q38982294-CEBEEFD2-2DBF-4E37-A705-00F2F8996FEA Q41017712-5F2D4BC4-20C9-4C13-B7EA-56AA083823C3 Q52309343-DB0E5830-5D7B-45F5-8BAF-2E25047388E9 Q57377313-2FAC3B0D-9480-464F-9448-8A4FEF97A928

P2860

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

http://www.wikidata.org/entity/Q34157584

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@ast

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@en

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@nl

type

label

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@ast

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@en

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@nl

prefLabel

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@ast

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@en

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@nl

P1433

Q34157584-51FEF8C7-7266-4C9A-B11C-8ECD1E963EBC

P1476

Q34157584-858FCE1A-15DD-4AC9-ACE8-9CC7F581A7A0

P2093

Q34157584-0491F4CB-444F-42F3-A5A7-C3B5AFA749A1

Q34157584-1AB2DA61-F604-4F33-AEC7-09F86E103F72

Q34157584-217B9024-11AF-417A-BC8E-A4CADC9C684E

Q34157584-2756491F-1582-41E6-9483-19884BB3A24E

Q34157584-276159F3-1B99-4D2A-B55A-37C8E624D31F

Q34157584-2AEB0D11-35C1-4B1D-88E6-9868D85A6C38

Q34157584-C31EBBA7-4063-478D-8F15-4E453E2F089C

Q34157584-DBE2E6E5-DEB0-4282-B890-C5CAC7AED158

P2860

Q34157584-182029D5-B283-4D53-9BB2-98F5C96EE56C

Q34157584-316D4FA7-E19B-47BD-8CF1-88CE9E3AE811

Q34157584-47A04837-B09D-48EE-B66A-F237A6FA5F7E

Q34157584-4F738104-98F8-466E-9BA9-1341F43D2A69

Q34157584-56C72C15-421A-4408-84B0-0C717D21EE98

Q34157584-576089BE-89B8-4FA7-B505-B9D7AD87A256

Q34157584-61C3F545-02CD-4B6F-ABD8-0DFE3191A948

Q34157584-69424169-7D21-4E75-B2CD-FABF36B4804D

Q34157584-6C725BDC-82D9-4207-A983-F75A900B6F3D

Q34157584-6D4F5787-0E6C-424D-9560-12C72829E9FC

P2888

Q34157584-A266F7FE-F6DC-4029-AA6A-D5A14CF3DD31

P304

Q34157584-8118D80B-93AC-4290-9393-487855553048

P31

Q34157584-BF5FD410-3FE0-4103-99AD-F44499AAEE27

P356

Q34157584-EE1E8075-F52C-4F9C-8EC9-D3EC2136E7B2

P407

Q34157584-CF66D069-3510-4D12-9757-9200A8BF54E8

P478

Q34157584-5E643CD4-7432-4FF9-BA83-F09C6E8C9B48

P50

Q34157584-338FE34B-57D9-4541-A118-426D3C1289D1

Q34157584-38259DD0-7B4A-4C78-9FCA-1A9DDAA9273E

Q34157584-D64FDD1A-0C0F-4FEE-8EB7-20454FCDCF24

P577

Q34157584-9C2B3F4E-45B4-41AF-B108-B679A0C6AB3C

P5875

Q34157584-D9C9C39A-6CEE-49E2-94D5-E0BF9C1D2CA8

P6179

Q34157584-44903E29-C4BC-4616-931E-DF0DEB115D17

P698

Q34157584-334927B1-95C3-43CE-90BC-103F643D7B70

P921

Q34157584-52FE72B4-942C-4FED-B6DE-0A2611BF412B

Q34157584-8C7E07BC-AF83-459B-B050-C454C97CC247

P932

Q34157584-5C8D3296-3171-49D0-B57A-0E64DA941B53

P356

P1433

Scientific Reports

P1476

Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.

@en

P2093

A-Ryeong Gwon

http://www.w3.org/2001/XMLSchema#string

Eunhee Hwang

http://www.w3.org/2001/XMLSchema#string

Ga-hee Bahn

http://www.w3.org/2001/XMLSchema#string

Junghee Yang

http://www.w3.org/2001/XMLSchema#string

Seol-Hee Kim

http://www.w3.org/2001/XMLSchema#string

Sora Bak

http://www.w3.org/2001/XMLSchema#string

Yeoheung Yoon

http://www.w3.org/2001/XMLSchema#string

Youngmin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Computational Design of Virus-Like Protein Assemblies on Carbon Nanotube Surfaces

Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease

A new method for pH triggered curcumin release by applying poly(L-lysine) mediated nanoparticle-congregation.

Target delivery and cell imaging using hyaluronic acid-functionalized graphene quantum dots.

Biological interactions of graphene-family nanomaterials: an interdisciplinary review.

The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage.

Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity.

Multi-functional nanocarriers to overcome tumor drug resistance

Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots.

Therapeutic nanoparticles to combat cancer drug resistance.

P2888

P304

6314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP06314

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265515533

http://www.w3.org/2001/XMLSchema#string

P6179

1045339789

http://www.w3.org/2001/XMLSchema#string

P698

25204358

http://www.w3.org/2001/XMLSchema#string

P921

P932

4159635

http://www.w3.org/2001/XMLSchema#string